PODD

INSULET CORP

NasdaqAdd to watchlist

Healthcare · Medical Devices

$134.68

−$3.24−2.35%

2026-09-10T20:00:00.000Z · marketstack

2 of 47tracked managers hold this· Q2 2026

Aug 11, 2026$147.48

+$2.78+1.92%over 1M

Day range13% of range

$134.11$138.66

Session

Previous close: $137.92
Open: $136.74
Volume: 1.87M
Avg volume: -
Day high: $138.66
Day low: $134.11

Fundamentals

Visualize fundamentals and more

Market cap: 9.33B
P/E ratio: 24.91
EPS (TTM): $5.41
Dividend yield: -
Beta: 1.06
Shares outstanding: 69.3M

Source SEC EDGAR · 9/10/2026

Tracked investors

As of Q2 2026 · 73 days ago · next update ~14 Nov 2026· what moved this quarter, onMeasure

2 fund managers this platform follows disclosed a position here, from quarterly SEC filings up to 45 days old; a manager may have sold since without yet having to say so.

Baillie Gifford
Baillie Gifford & Co
$310.94M
0.28%of book
Joel Greenblatt
Gotham Asset Management
$12.9M
0.03%of book

Manager	Position	Share of their book	Last change
Baillie Gifford Baillie Gifford & Co	$310.94M	0.28%
Joel Greenblatt Gotham Asset Management	$12.9M	0.03%

Share price, with each quarter a tracked manager’s position changed shaded across the range it traded in.

140210280350

135

now

Q3 '24

Q4 '24

Q1 '25

Q2 '25

Q3 '25

Q4 '25

Q1 '26

Q2 '26

Hover a shaded quarter to see it moved. Who, and the range they traded in, is onBespoke

13F filings cover US-listed shares only (not cash, bonds, shorts, or private holdings) and are never a recommendation to do the same.

Risk factors, year on year

Item 1AFebruary 2026 10-KFebruary 2025as filed.

added: 40
dropped: 53
re-drafted: 35

Out of 104 passages in this year’s Item 1A.

New this year

We expect to continue to derive nearly all our revenue from our Omnipod product platform. Accordingly, our ability to continue to generate revenue is highly reliant on our ability to successfully market and sell our Omnipod products to new and existing …

92 more passages, included withBespoke

Recent activity

2 more events, included withMeasure

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Companies like INSULET CORP

Also filed under Medical Devices, ranked by how closely they sit beside PODD.

SYKSTRYKER CORP
BSXBOSTON SCIENTIFIC CORP
ABTABBOTT LABORATORIES
MDTMedtronic plc
DXCMDEXCOM INC
EWEdwards Lifesciences Corp

Ask about INSULET CORP

The assistant answers from what PODD has actually filed: 17 annual reports filed with the SEC, 13F positions from the 2 tracked investors who hold it and 6 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from PODD's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding INSULET CORP, and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

What an account lets you do with INSULET CORP

Separate the decisions from the paperwork
Every Form 4 PODD insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about INSULET CORP's fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free accountSee what the paid plans add

Free, no card, and it does not expire.